Open AccessAntecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients
Author(s) -
Mauro Gori,
Carlo Berzuini,
Emilia D’Elia,
Arianna Ghirardi,
Luisa Bernardinelli,
Antonello Gavazzi,
Giulio Balestrieri,
Andrea Giammarresi,
Roberto Trevisan,
Fabiano Di Marco,
Antonio Bellasi,
Mariangela Amoroso,
Fabiano Di Marco,
Luca Novelli,
Bianca Magro,
G. Mangia,
Ferdinando Luca Lorini,
Giulio Guagliumi,
S. Fagiuoli,
Gianfranco Parati,
Michele Senni
Publication year - 2021
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/hjh.0000000000003059
Subject(s) - medicine , odds ratio , antecedent (behavioral psychology) , confidence interval , population , propensity score matching , renin–angiotensin system , cardiology , blood pressure , psychology , developmental psychology , environmental health
The effect of renin-angiotensin system inhibitors (RASIs) on mortality in patients with coronavirus disease (Covid-19) is debated. From a cohort of 1352 consecutive patients admitted with Covid-19 to Papa Giovanni XXIII Hospital in Bergamo, Italy, between February and April 2020, we selected and studied hypertensive patients to assess whether antecedent (prior to hospitalization) use of RASIs might affect mortality from Covid-19 according to age.